Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001596771-17-000062

Chief Development Officer acquired 215,453 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bachinski Thomas · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2017-07-20 Grant or award : show line 1 in the form +215,453 215,453 D
Loading xslF345X03/primary_doc.xml…